A higher T-stage (Fig. 4F) was associated with the overexpression of CENPM in contrast to the N-stage (Fig. 4G), and triple-negative breast cancer exhibited greater CENPM expression when compared to hormone receptor-positive breast cancer (Fig. 4H). This evidence concerns the gene NR4A1 and triple-negative breast carcinoma.